1 Further, those living with T2DM have a large array of therapeutic options for controlling blood glucose beyond exogenous insulin, and more opportunities exist for evaluating the CV safety of therapies in this patient population
Kinsella S, Smith CW, McKenna K, Hailemariam M, Mazziotta F, Martin LE, et al
Genetic Insights Into GLP-1 Tolerance and Nausea Sensitivity The PlexusDx Precision Peptide Genetic Test analyzes GLP1R (rs6923761) variants that relate to GLP-1 and related signaling pathways
Whether you are using a branded pen or a syringe for a compounded medication, the principles of subcutaneous delivery remain the same: target the fat, rotate your sites, and prioritize sterility
Does it help with weight management